Ebola
The Ebola epidemic in western Africa has demonstrated that public health, and public health ethics, is global and not merely local. Recognizing that public health preparedness requires ethics preparedness, the Bioethics Commission sought to create recommendations that support policies and practices that enable a proactive response to public health epidemics.
SESSION 7: MEMBER DISCUSSION
DR. GUTMANN: Other ‑‑ we're going to move on to Ebola, from the brain to Ebola. Okay? Okay.
SESSION 5: ROUNDTABLE DISCUSSION
DR. GUTMANN: Well, first of all, welcome back. By unanimous agreement among the commission, we had the best group of presenters today, bar none, so that means that our expectations are very high for this final panel.
I always ask one question and go down and ask you all to give one succinct answer to it, and then we'll open up.
SESSION 4: HISTORICAL, SOCIOLOGICAL, AND LEGAL PERSPECTIVES ON U.S. POLICIES INTENDED TO PREVENT EBOLA IN THE UNITED STATES
DR. WAGNER: This is the final panel of today, and it's to discuss the historical and sociological and legal perspectives on U.S. policies that are intended to prevent Ebola in the United States. Our first speaker will be Dr. Howard Markel who is the George E. Wantz distinguished professor of the history of medicine and the founding director of the Center for the History of Medicine at the University of Michigan.
SESSION 3: HOW U.S. PUBLIC ATTITUDES AND POLICIES INTENDED TO PREVENT EBOLA IN THE UNITED STATES IMPACT AFFECTED COMMUNITIES
DR. GUTMANN: Welcome, everybody. Welcome back. This is our third panel for the day and the first two panels were terrific and I’m sure this one will be as well.
SESSION 2: PUBLIC HEALTH PERSPECTIVES ON THE CURRENT EBOLA EPIDEMIC IN WESTERN AFRICA
DR. WAGNER: All right, Commissioners. Let’s—since our guests are ready to go, let’s the rest of us also do that.
Delighted to welcome our next panel, and we’ll use the same process as before. One by one, we will introduce you and ask you to speak, and then we’ll introduce and move each successive—to each successive panelist and hold all questions until all three of you have had a chance to speak.
DR. GUTMANN: I would love to welcome everybody. I’m Amy Gutmann. I’m president of the University of Pennsylvania, and I have the privilege of chairing the Presidential Commission for the Study of Bioethical Issues. On behalf of myself and our vice chair, Jim Wagner, who is the president of Emory University, I’d like to welcome you to our 20th meeting.
Let me begin by noting the presence of our designated federal official who is also Bioethics Commission executive director, Lisa M. Lee. Lisa, please stand so we know who you are. We all do, the commission members.
Pages
This is a work of the U.S. Government and is not subject to copyright protection in the United States. Foreign copyrights may apply.
